PharmEasy founders' All Home raises Rs 200 cr at doubled Rs 2,000 cr valuation
All Home, the full-stack building materials startup from PharmEasy's founders, closed a Rs 200 crore round led by Bessemer at a Rs 2,000 crore valuation—double its June 2025 seed. The venture posts Rs 180 crore FY26 revenue and Rs 400 crore ARR across surfaces, hardware, facades and lighting via 7 brand partners.
What happened
All Home, a building materials full-stack startup by PharmEasy founders, raised Rs 200 crore led by Bessemer at Rs 2,000 crore valuation, doubling from seed.
Key facts
- Rs 200 crore raised
- Rs 2,000 crore valuation
- Rs 180 crore FY26 revenue
- Rs 400 crore ARR
- $20 million seed June 2025
- 7 brand partners
- 4 categories
Why this matters
A Rs 2,000 cr full-stack aggregator consolidating surfaces, hardware, facades and lighting is emerging as a strategic chokepoint for legacy building materials incumbents—partnership or pre-emptive stake conversations should move up the queue.
What to watch
- FY26 audited financials disclosing take rate and contribution margin
- Asian Paints/Pidilite/Berger reaction via D2C or marketplace counters
- Infra Market, HomeLane, Livspace competitive pricing moves
- Bessemer doubling down in follow-on or new lead emerging
- Real estate cycle data — housing launches and completions in H2 FY26
- Any GST/input credit policy shifts on building materials
- Watch for showroom expansion announcements in Bengaluru/Mumbai/NCR
- Track brand partner additions beyond current 7 (tiles, sanitaryware, modular kitchens)
- Expect contractor/architect loyalty program launch to lock channel
- Likely private label SKUs in surfaces/hardware to lift margins
- Tech hires in catalog, BIM integration, and last-mile logistics